Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
1.650
-0.110 (-6.25%)
Oct 23, 2026, 4:00 PM EDT - Market closed
Serina Therapeutics Market Cap
Serina Therapeutics has a market cap or net worth of $41.91 million as of October 23, 2026. It is the 31,400th most valuable company in the world and the 4,730th biggest in the United States. Its market cap has decreased by 23.07% in one year.
Market Cap
41.91M
Enterprise Value
22.64M
1-Year Change
-23.07%
Global Rank
Country Rank
#4,730 United States
Category
ChartMarket Cap Chart
Since March 27, 2024, Serina Therapeutics's market cap has decreased from $125.13M to $41.91M, a decrease of -66.51%. That is a compound annual growth rate of -34.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 41.91M | 105.44% |
| Dec 31, 2025 | 20.40M | -56.64% |
| Dec 31, 2024 | 47.05M | -62.40% |
| Mar 27, 2024 | 125.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kalaris Therapeutics | 44.52M |
| Hyperion DeFi | 43.51M |
| Biomea Fusion | 43.50M |
| Adicet Bio | 42.95M |
| Estrella Immunopharma | 42.85M |
| Annovis Bio | 42.58M |
| Grace Therapeutics | 40.60M |
| INmune Bio | 40.52M |